CNPOF Stock
Price Chart
CNPOF Financial and Trading Overview
stock price | 0.08 |
Previous Close | 0.09 |
Open | 0.09 |
Bid | 0 x 0 |
Ask | 0 x 0 |
Day's Range | 0.09 - 0.1 |
52 Week Range | 0.08 - 0.57 |
Volume | 35.71K |
Avg. Volume | 33.88K |
Market Cap | 13.83M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
CNPOF Valuation Measures
Enterprise Value | 26.7M |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 2.0318518 |
Price/Book (mrq) | 0.14236312 |
Enterprise Value/Revenue | 3.922 |
Enterprise Value/EBITDA | -1.61 |
Trading Information
Stock Price History
Beta (5Y Monthly) | N/A |
52-Week Change | -82.36% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.57 |
52 Week Low | 0.08 |
50-Day Moving Average | 0.09 |
200-Day Moving Average | 0.2 |
CNPOF Share Statistics
Avg. Volume (3 month) | 33.88K |
Avg. Daily Volume (10-Days) | 28.79K |
Shares Outstanding | 135.41M |
Float | 125.65M |
Short Ratio | N/A |
% Held by Insiders | 19.17% |
% Held by Institutions | 24.27% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | March 31, 2023 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | March 31, 2024 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | -265.84% |
Gross Margin | 35.34% |
EBITDA Margin | -243.58% |
Management Effectiveness
Return on Assets (ttm) | -3.76% |
Return on Equity (ttm) | -101.46% |
Income Statement
Revenue (ttm) | 6.81M |
Revenue Per Share (ttm) | 0.04 |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | N/A |
EBITDA | -16581000 |
Net Income Avi to Common (ttm) | -179259008 |
Diluted EPS (ttm) | -1.06 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 97.86M |
Total Cash Per Share (mrq) | 0.62 |
Total Debt (mrq) | 110.32M |
Total Debt/Equity (mrq) | 101.35 |
Current Ratio (mrq) | 16.389 |
Book Value Per Share (mrq) | 0.694 |
Cash Flow Statement
Operating Cash Flow (ttm) | -23358000 |
Levered Free Cash Flow (ttm) | -26301284 |
Profile of
Country | United States |
State | ON |
City | Toronto |
Address | 40 King Street West |
ZIP | M5H 3Y2 |
Phone | 416-583-5945 |
Website | https://www.rivcapital.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
RIV Capital Inc., formerly known as Canopy Rivers Inc., is a venture capital firm. The firm is a stage agnostic, with seed to sale, although it prefers to invest in series A to C rounds. It prefers to make investments in cannabis sector with focus on burgeoning marijuana companies and sectors like agriculture and food sciences, production, processing, pharmaceuticals and biotechnology, software and data, hardware, consumer products and accessories, wellness products, retail and distribution, and media and content. The firm also focuses on beverages, capsules and concentrates, edibles, dry flower / pre-rolls, vaporizers and hardware, pet products, and topicals. In agriculture and food sciences firm focuses in invest plant science, soil science, food science, animal science and environmental science. In production firm focuses in Indoor cultivation, greenhouse cultivation, outdoor cultivation, nursery cultivation and fermentation. In processing firm focuses in harvesting, extraction and purification, packaging, food and beverage processing and laboratory testing services. In pharmaceuticals and biotechnology firm focuses in pharmaceutical discovery and development, delivery method (ex: pill, soft gel, tincture), biosynthetic derived cannabinoids and other molecules, medical devices (ex: inhalers) and lab equipment. In consumer products and accessories firm focuses in edibles, beverages, inhalable, cosmetics and cannabis consumption accessories. In retail and distribution firm focuses in licensed brick and mortar retailers, pharmacies, online consumer marketplaces, delivery services, and others. The firm invests in opportunities globally. The firm prefers to invest in check sizes have ranged from CA$1 million ($0.71 million) to $40 million ($28.45 million), but more typical investment range is between CA$5 million ($3.6 million) to CA$10 million ($7.1 million). The firm is focused on making minority stake investments. Firm employ diverse investment structures including debt, preferred and common equity, and production-linked royalties. RIV Capital Inc. was founded on 2017 and is based in Toronto, Canada.
Q&A For Stock
What is a current CNPOF stock price?
CNPOF stock price today per share is 0.08 .
How to purchase stock?
You can buy CNPOF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ?
The stock symbol or ticker of is CNPOF.
Which industry does the company belong to?
The industry is Drug Manufacturers-Specialty & Generic.
How many shares does have in circulation?
The max supply of shares is 0.
What is Price to Earnings Ratio (PE Ratio)?
PE Ratio is 0.00000000 now.
What was earnings per share over the trailing 12 months (TTM)?
EPS is 0 over the trailing 12 months.
Which sector does the company belong to?
The sector is Healthcare.